MSIAN GENOMICS RES CENTRE BHDMSIAN GENOMICS RES CENTRE BHDMSIAN GENOMICS RES CENTRE BHD

MSIAN GENOMICS RES CENTRE BHD

No trades
See on Supercharts
Market capitalization
‪57.63 M‬MYR
−0.110MYR
‪−14.34 M‬MYR
‪8.57 M‬MYR
‪126.23 M‬
Beta (1Y)
0.03

About MSIAN GENOMICS RES CENTRE BHD

Headquarters
Petaling Jaya
Founded
2004
ISIN
MYQ0155OO000
FIGI
BBG0015W8SF5
Malaysian Genomics Resource Centre Bhd. is an investment holding company, which engages in the provision of healthcare services. The company was founded by Robert George Hercus and Munirah binti Haji Abdul Hamid on May 18, 2004 and is headquartered in Petaling Jaya, Malaysia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of MGRC is 0.420 MYR — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on MYX exchange MSIAN GENOMICS RES CENTRE BHD stocks are traded under the ticker MGRC.
MSIAN GENOMICS RES CENTRE BHD is going to release the next earnings report on Nov 19, 2024. Keep track of upcoming events with our Earnings Calendar.
MGRC stock is 0% volatile and has beta coefficient of 0.03. Check out the list of the most volatile stocks — is MSIAN GENOMICS RES CENTRE BHD there?
Yes, you can track MSIAN GENOMICS RES CENTRE BHD financials in yearly and quarterly reports right on TradingView.
MGRC stock has fallen by 2.33% compared to the previous week, the month change is a 3.45% fall, over the last year MSIAN GENOMICS RES CENTRE BHD has showed a 25.66% decrease.
MGRC net income for the last quarter is ‪−6.07 M‬ MYR, while the quarter before that showed ‪−1.45 M‬ MYR of net income which accounts for −318.99% change. Track more MSIAN GENOMICS RES CENTRE BHD financial stats to get the full picture.
Today MSIAN GENOMICS RES CENTRE BHD has the market capitalization of ‪57.63 M‬, it has decreased by 1.16% over the last week.
Like other stocks, MGRC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MSIAN GENOMICS RES CENTRE BHD stock right from TradingView charts — choose your broker and connect to your account.
MGRC reached its all-time high on Oct 29, 2021 with the price of 2.720 MYR, and its all-time low was 0.140 MYR and was reached on Mar 20, 2020.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MSIAN GENOMICS RES CENTRE BHD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MSIAN GENOMICS RES CENTRE BHD stock shows the sell signal. See more of MSIAN GENOMICS RES CENTRE BHD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MSIAN GENOMICS RES CENTRE BHD EBITDA is ‪−17.14 M‬ MYR, and current EBITDA margin is −154.31%. See more stats in MSIAN GENOMICS RES CENTRE BHD financial statements.